Determination of IGF-II levels in human serum using the erythroleukemia cell line K562.
A homologous radioreceptor assay (RRA) has been developed for Insulin-like Growth Factor II (IGF II) using the human erythroleukemia cell line K562. These cells have binding sites for insulin and IGF-II but not for Insulin-like Growth Factor I (IGF I). All samples were dissociated and separated from binding proteins by gel filtration at acidic pH. In healthy adults the mean serum level of radioreceptor assayable IGF II (RRA-IGF II) and 95% confidence limits were 965 ng/ml and 717-1299 ng/ml, respectively. The mean level in GH deficient patients was significantly lower (p less than 0.001) compared with healthy subjects whereas no change was found in patients with acromegaly and uremia. Slightly lowered levels of RRA-IGF II were found in one patient with a tumor induced hypoglycemia.
Spadoni
G L
GL
Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.
Tally
M
M
Florell
K
K
Enberg
G
G
Hall
K
K
D000172:Acromegaly / Q000097:blood; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D013006:Growth Hormone / Q000172:deficiency; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000209:etiology; D007335:Insulin-Like Growth Factor II / Q000032:analysis*; D007457:Iodine Radioisotopes; D004915:Leukemia, Erythroblastic, Acute; D008297:Male; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000150:complications; D011869:Radioligand Assay; D012016:Reference Values; D013002:Somatomedins / Q000032:analysis*; D014407:Tumor Cells, Cultured; D014511:Uremia / Q000097:blood
D007457:Iodine Radioisotopes; D013002:Somatomedins; D007335:Insulin-Like Growth Factor II; D013006:Growth Hormone